Pub Date : 2023-07-05DOI: 10.24875/recice.m23000391
Lisa Bianco, A. Sabaté-Rotés, A. Torrent‐Vernetta, and Pedro Betrián-Blasco
a Unidad de Hemodinámica Pediátrica, Hospital Vall d’Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain b Servicio de Cardiología Pediátrica, Hospital Vall d’ Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain c Servicio de Alergia Pediátrica, Neumología Pediátrica y Fibrosis Quística, Hospital Vall d’ Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain d Centro de Investigación en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Spain Scientific letter
{"title":"Atrial flow regulator and atrial septostomy in pediatric pulmonary hypertension: when procedure and device match","authors":"Lisa Bianco, A. Sabaté-Rotés, A. Torrent‐Vernetta, and Pedro Betrián-Blasco","doi":"10.24875/recice.m23000391","DOIUrl":"https://doi.org/10.24875/recice.m23000391","url":null,"abstract":"a Unidad de Hemodinámica Pediátrica, Hospital Vall d’Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain b Servicio de Cardiología Pediátrica, Hospital Vall d’ Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain c Servicio de Alergia Pediátrica, Neumología Pediátrica y Fibrosis Quística, Hospital Vall d’ Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain d Centro de Investigación en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Spain Scientific letter","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48493177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-07-05DOI: 10.24875/recice.m23000395
Paulo Éden Santos, F. Ballesteros, Alexandro Rodríguez, and José Luis Zunzunegui
Introduction and objectives: Performing cardiac catheterization can be challenging regarding the management of congenital heart disease. Therefore, the use of risk scoring or grading systems can help us plan the procedure. Back in 2015, the Congenital Cardiac Interventional Study Consortium developed and validated a system called CRISP (Catheterization risk score for pediatrics), which predicted the risk of serious adverse events (SAEs) prior to cardiac catheterization. Our aim was to use and validate the same scoring system to predict SAEs associated with cardiac catheterization in a Spanish pediatric hospital. Methods: A retrospective descriptive study was performed between January 2016 and May 2017. To create the area under the curve, the expected number of events was correlated with the overall number of cases (compared to the original CRISP). Pearson’s chi-square test was used to assess the performance of the scoring system. Results: A total of 516 patients were successfully enrolled, 26.6% of whom were < 1 year-old [range, 1 day to 18 years], 56.5% were males, and 17% weighed < 5 kg. Around 63.3% of the procedures performed were percutaneous compared to 1.2% that were hybrid. A total of 40 SAEs were found to be amenable to immediate correction with no associated mortality. CRISP showed good discrimination with an area under the curve of 0.71 (95%CI, - 0.66-0.91) compared to the original score of 0.74, and adequate goodness of fit with Pearson’s chi-square test of 8.26 ( P < .08). Conclusions: Despite the performance of highly complex procedures, the rate of SAEs was similar to the one previously published. CRISP has proven to be a good benchmarking and risk stratification tool. Therefore, it can be successfully used in the Spanish pediatric population and have a positive impact on patient care like helping during pre-and post-catheterization care planning.
{"title":"Use of a pediatric risk score for cardiac catheterization in a Spanish population with congenital heart disease","authors":"Paulo Éden Santos, F. Ballesteros, Alexandro Rodríguez, and José Luis Zunzunegui","doi":"10.24875/recice.m23000395","DOIUrl":"https://doi.org/10.24875/recice.m23000395","url":null,"abstract":"Introduction and objectives: Performing cardiac catheterization can be challenging regarding the management of congenital heart disease. Therefore, the use of risk scoring or grading systems can help us plan the procedure. Back in 2015, the Congenital Cardiac Interventional Study Consortium developed and validated a system called CRISP (Catheterization risk score for pediatrics), which predicted the risk of serious adverse events (SAEs) prior to cardiac catheterization. Our aim was to use and validate the same scoring system to predict SAEs associated with cardiac catheterization in a Spanish pediatric hospital. Methods: A retrospective descriptive study was performed between January 2016 and May 2017. To create the area under the curve, the expected number of events was correlated with the overall number of cases (compared to the original CRISP). Pearson’s chi-square test was used to assess the performance of the scoring system. Results: A total of 516 patients were successfully enrolled, 26.6% of whom were < 1 year-old [range, 1 day to 18 years], 56.5% were males, and 17% weighed < 5 kg. Around 63.3% of the procedures performed were percutaneous compared to 1.2% that were hybrid. A total of 40 SAEs were found to be amenable to immediate correction with no associated mortality. CRISP showed good discrimination with an area under the curve of 0.71 (95%CI, - 0.66-0.91) compared to the original score of 0.74, and adequate goodness of fit with Pearson’s chi-square test of 8.26 ( P < .08). Conclusions: Despite the performance of highly complex procedures, the rate of SAEs was similar to the one previously published. CRISP has proven to be a good benchmarking and risk stratification tool. Therefore, it can be successfully used in the Spanish pediatric population and have a positive impact on patient care like helping during pre-and post-catheterization care planning.","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45119613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-29DOI: 10.24875/recice.m23000392
Cristina Morante Perea, Tomás Cantón Rubio, Luis Manuel Hernando Romero, J. B. Buendía Miñano, J. Moreu Burgos, and Luis Rodríguez Padial
, Coronary malperfusion in patients with aortic dissection further worsens prognosis due to compromised myocardial blood flow. The incidence rate of coronary disease goes from 9% to 10% according to various registries. 1,2 Also, it can occur simultaneously at the beginning of dissection, during the patient transfer or in the middle of surgery. The management of these patients is still a matter of discussion. The optimal time of myocardial reperfusion is 90 min, a timeframe that cannot be guaranteed with surgical revascularization associated with aortic valve repair surgery. This is the case of a 65-year-old man. The patient was a smoker with chronic kidney disease who was admitted to our center as a «myocar-dial infarction code» case due to suspected anterior ST-segment elevation acute coronary syndrome. The coronary angiography revealed the presence of a type A aortic dissection with coronary malperfusion due to left main coronary artery (LMCA) occlusion. The patient had reported to his tertiary referral center with a 30-min history of oppressive retrosternal chest pain. Upon arrival at the emergency room, he remained symptomatic and hemody-namically unstable (pale, sweaty,
{"title":"Coronary malperfusion in acute type A aortic dissection","authors":"Cristina Morante Perea, Tomás Cantón Rubio, Luis Manuel Hernando Romero, J. B. Buendía Miñano, J. Moreu Burgos, and Luis Rodríguez Padial","doi":"10.24875/recice.m23000392","DOIUrl":"https://doi.org/10.24875/recice.m23000392","url":null,"abstract":", Coronary malperfusion in patients with aortic dissection further worsens prognosis due to compromised myocardial blood flow. The incidence rate of coronary disease goes from 9% to 10% according to various registries. 1,2 Also, it can occur simultaneously at the beginning of dissection, during the patient transfer or in the middle of surgery. The management of these patients is still a matter of discussion. The optimal time of myocardial reperfusion is 90 min, a timeframe that cannot be guaranteed with surgical revascularization associated with aortic valve repair surgery. This is the case of a 65-year-old man. The patient was a smoker with chronic kidney disease who was admitted to our center as a «myocar-dial infarction code» case due to suspected anterior ST-segment elevation acute coronary syndrome. The coronary angiography revealed the presence of a type A aortic dissection with coronary malperfusion due to left main coronary artery (LMCA) occlusion. The patient had reported to his tertiary referral center with a 30-min history of oppressive retrosternal chest pain. Upon arrival at the emergency room, he remained symptomatic and hemody-namically unstable (pale, sweaty,","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41746576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-29DOI: 10.24875/recice.m23000396
M. Martínez‐Sellés
{"title":"Doctor, I want a TAVI! Should patients choose the type of aortic valve procedure they want?","authors":"M. Martínez‐Sellés","doi":"10.24875/recice.m23000396","DOIUrl":"https://doi.org/10.24875/recice.m23000396","url":null,"abstract":"","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47264998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-21DOI: 10.24875/recice.m23000384
Pedro Luis Martín Lorenzo
,
{"title":"Debate. Cerebral embolic protection systems in TAVI: there is not enough evidence available","authors":"Pedro Luis Martín Lorenzo","doi":"10.24875/recice.m23000384","DOIUrl":"https://doi.org/10.24875/recice.m23000384","url":null,"abstract":",","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49326574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-21DOI: 10.24875/recice.m23000374
P. Jiménez Quevedo
Answer: Former studies described that, during TAVI, loose debris like arterial wall fragments, thrombi, valve tissue, and foreign bodies often enters the circulation.1 These particles are the aftermath of the device making its way through the aorta towards the aortic annulus, the positioning and displacement of a calcified stenotic valve between the new valve stent and the aortic wall, and further manipulations to optimize results (postdilatation). To this date, numerous studies have been published on the safety and efficacy profile of these cerebral protection devices (CPD). Specifically, 4 randomized clinical trials have been published associated with the SENTINEL (Boston Scientific Corp., United States): MISTRAL-C,2 CLEAN TAVI,3 SENTINEL,4 and PROTECTED TAVR5 we can talk about later on. The MISTRAL-C trial used cerebral magnetic resonance imaging to demonstrate a significant reduction in the number of patients with multiple cerebral lesions (20% vs 0%; P = .03) and less cognitive impairment (4% vs 27%; P = .017). Similarly, the CLEAN TAVI trial also reported fewer novel lesions and of a smaller volume without any differences being reported in the number of clinical events in the group that used CPD. These studies demonstrated fragments being captured in almost in 100% of the cases. Several metanalyses6-13 also confirm these results regarding the number and volume of cerebral lesions described, and even some show lower rates of strokes in the DPC group.10,12,13 Therefore, we not only have the visual in situ demonstration of the particles being captured in the baskets following implantation, but also scientific evidence that CPD are effective capturing fragments released during TAVI that can land in cerebral circulation, thus lowering the number of cerebral lesions found on the magnetic resonance imaging during the procedure. However, whether capturing such particles with the device has a clear clinical benefit for its widespread use is still to be elucidated.
{"title":"Debate. Cerebral embolic protection systems in TAVI: there is some supportive evidence","authors":"P. Jiménez Quevedo","doi":"10.24875/recice.m23000374","DOIUrl":"https://doi.org/10.24875/recice.m23000374","url":null,"abstract":"Answer: Former studies described that, during TAVI, loose debris like arterial wall fragments, thrombi, valve tissue, and foreign bodies often enters the circulation.1 These particles are the aftermath of the device making its way through the aorta towards the aortic annulus, the positioning and displacement of a calcified stenotic valve between the new valve stent and the aortic wall, and further manipulations to optimize results (postdilatation). To this date, numerous studies have been published on the safety and efficacy profile of these cerebral protection devices (CPD). Specifically, 4 randomized clinical trials have been published associated with the SENTINEL (Boston Scientific Corp., United States): MISTRAL-C,2 CLEAN TAVI,3 SENTINEL,4 and PROTECTED TAVR5 we can talk about later on. The MISTRAL-C trial used cerebral magnetic resonance imaging to demonstrate a significant reduction in the number of patients with multiple cerebral lesions (20% vs 0%; P = .03) and less cognitive impairment (4% vs 27%; P = .017). Similarly, the CLEAN TAVI trial also reported fewer novel lesions and of a smaller volume without any differences being reported in the number of clinical events in the group that used CPD. These studies demonstrated fragments being captured in almost in 100% of the cases. Several metanalyses6-13 also confirm these results regarding the number and volume of cerebral lesions described, and even some show lower rates of strokes in the DPC group.10,12,13 Therefore, we not only have the visual in situ demonstration of the particles being captured in the baskets following implantation, but also scientific evidence that CPD are effective capturing fragments released during TAVI that can land in cerebral circulation, thus lowering the number of cerebral lesions found on the magnetic resonance imaging during the procedure. However, whether capturing such particles with the device has a clear clinical benefit for its widespread use is still to be elucidated.","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45984924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-21DOI: 10.24875/recice.m23000388
V. Juárez Olmos, O. Gonzalez-Fernandez, Alfonso Jurado Román, S. Jiménez Valero, C. Contreras Lorenzo, and Almudena Castro Conde
The patent oval foramen (PFO) is present in nearly 1 out of every 4 people
卵圆孔未闭(PFO)存在于近1 / 4的人
{"title":"Provoked exercise desaturation in patients with patent foramen ovale, infrequent or underdiagnosed?","authors":"V. Juárez Olmos, O. Gonzalez-Fernandez, Alfonso Jurado Román, S. Jiménez Valero, C. Contreras Lorenzo, and Almudena Castro Conde","doi":"10.24875/recice.m23000388","DOIUrl":"https://doi.org/10.24875/recice.m23000388","url":null,"abstract":"The patent oval foramen (PFO) is present in nearly 1 out of every 4 people","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47437113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-20DOI: 10.24875/recice.m23000377
M. Maeztu, L. Ruiz, Leire Andraka, M. Larman, G. Lasa, and Jesús Roberto Sáez
{"title":"Transfemoral valve-in-MAC implantation due to severe radiation-induced mitral stenosis","authors":"M. Maeztu, L. Ruiz, Leire Andraka, M. Larman, G. Lasa, and Jesús Roberto Sáez","doi":"10.24875/recice.m23000377","DOIUrl":"https://doi.org/10.24875/recice.m23000377","url":null,"abstract":"","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49080163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-08DOI: 10.24875/recice.m23000382
E. Arroyo-Úcar, B. Ibáñez Cabeza, and Gonzalo Pizarro Sánchez
{"title":"Impact of ischemic preconditioning on the radial artery vasomotor function","authors":"E. Arroyo-Úcar, B. Ibáñez Cabeza, and Gonzalo Pizarro Sánchez","doi":"10.24875/recice.m23000382","DOIUrl":"https://doi.org/10.24875/recice.m23000382","url":null,"abstract":"","PeriodicalId":34613,"journal":{"name":"REC Interventional Cardiology English Ed","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43948379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：